Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease

Khairy, Paul, Van Hare, George F., Balaji, Seshadri, Berul, Charles I., Cecchin, Frank, Cohen, Mitchell I., Daniels, Curt J., Deal, Barbara J., Dearani, Joseph A., Groot, Natasja de, Dubin, Anne M., Harris, Louise, Janousek, Jan, Kanter, Ronald J., Karpawich, Peter P., Perry, James C., Seslar, Stephen P., Shah, Maully J., Silka, Michael J., Triedman, John K., Walsh, Edward P., Warnes, Carole A.·2014·Canadian Journal of Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cjca.2014.09.002

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 584

  1. Khairy, 2010, Changing mortality in congenital heart disease, J Am Coll Cardiol, 56, 1149, 10.1016/j.jacc.2010.03.085 · DOI · Paper page
  2. Marelli, 2007, Congenital heart disease in the general population: changing prevalence and age distribution, Circulation, 115, 163, 10.1161/CIRCULATIONAHA.106.627224 · DOI · Paper page
  3. Moons, 2006, Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey, Eur Heart J, 27, 1324, 10.1093/eurheartj/ehi858 · DOI
  4. Walsh, 2007, Arrhythmias in adult patients with congenital heart disease, Circulation, 115, 534, 10.1161/CIRCULATIONAHA.105.592410 · DOI · Paper page
  5. Khairy, 2008, EP challenges in adult congenital heart disease, Heart Rhythm, 5, 1464, 10.1016/j.hrthm.2008.05.026 · DOI
  6. Warnes, 2008, ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary, J Am Coll Cardiol, 52, 1890, 10.1016/j.jacc.2008.10.002 · DOI · Paper page
  7. 2010, Methodology manual and policies from the ACCF/AHA task force on practice guidelines, American College of Cardiology Foundation and American Heart Association, 1
  8. Tutarel, 2014, Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality, Eur Heart J, 35, 725, 10.1093/eurheartj/eht257 · DOI · Paper page
  9. Wren, 2001, Survival with congenital heart disease and need for follow up in adult life, Heart, 85, 438, 10.1136/heart.85.4.438 · DOI · Paper page
  10. Warnes, 2005, The adult with congenital heart disease: born to be bad?, J Am Coll Cardiol, 46, 1, 10.1016/j.jacc.2005.02.083 · DOI · Paper page
  11. van der Bom, 2011, The changing epidemiology of congenital heart disease, Nat Rev Cardiol, 8, 50, 10.1038/nrcardio.2010.166 · DOI · Paper page
  12. Moons, 2006, Prevalence of cardiovascular risk factors in adults with congenital heart disease, Eur J Cardiovasc Prev Rehabil, 13, 612, 10.1097/01.hjr.0000197472.81694.2b · DOI · Paper page
  13. Afilalo, 2009, Geriatric congenital heart disease: trends in prevalence and predictors of mortality, Circulation, 120, S562
  14. Kaemmerer, 2003, Emergency hospital admissions and three-year survival of adults with and without cardiovascular surgery for congenital cardiac disease, J Thorac Cardiovasc Surg, 126, 1048, 10.1016/S0022-5223(03)00737-2 · DOI
  15. Kaemmerer, 2008, Management of emergencies in adults with congenital cardiac disease, Am J Cardiol, 101, 521, 10.1016/j.amjcard.2007.09.110 · DOI
  16. Oechslin, 2000, Mode of death in adults with congenital heart disease, Am J Cardiol, 86, 1111, 10.1016/S0002-9149(00)01169-3 · DOI · Paper page
  17. Verheugt, 2010, Mortality in adult congenital heart disease, Eur Heart J, 31, 1220, 10.1093/eurheartj/ehq032 · DOI · Paper page
  18. Escudero, 2013, Electrophysiologic considerations in congenital heart disease and their relationship to heart failure, Can J Cardiol, 29, 821, 10.1016/j.cjca.2013.02.016 · DOI
  19. Kanter, 1997, Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease, Pacing Clin Electrophysiol, 20, 502, 10.1111/j.1540-8159.1997.tb06207.x · DOI · Paper page
  20. Khairy, 2006, Arrhythmias in adult congenital heart disease, Expert Rev Cardiovasc Ther, 4, 83, 10.1586/14779072.4.1.83 · DOI
  21. Khairy, 2009, Cardiac arrhythmias in congenital heart diseases, Indian Pacing Electrophysiol J, 9, 299
  22. Bouchardy, 2009, Atrial arrhythmias in adults with congenital heart disease, Circulation, 120, 1679, 10.1161/CIRCULATIONAHA.109.866319 · DOI · Paper page
  23. Epstein, 2001, Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease, J Cardiovasc Electrophysiol, 12, 671, 10.1046/j.1540-8167.2001.00671.x · DOI
  24. Khairy, 2003, Monckeberg's sling, Can J Cardiol, 19, 717
  25. Seslar, 2006, Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease, J Cardiovasc Electrophysiol, 17, 359, 10.1111/j.1540-8167.2006.00354.x · DOI
  26. Khairy, 2010, Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study, Circulation, 122, 868, 10.1161/CIRCULATIONAHA.109.928481 · DOI · Paper page
  27. Khairy, 2004, Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures, Cardiol Young, 14, 284, 10.1017/S1047951104003063 · DOI · Paper page
  28. Khairy, 2008, Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery, Circulation, 117, 85, 10.1161/CIRCULATIONAHA.107.738559 · DOI · Paper page
  29. Philip, 2012, Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease, Congenital heart disease, 7, 392, 10.1111/j.1747-0803.2012.00649.x · DOI
  30. Beauchesne, 2002, Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries, J Am Coll Cardiol, 40, 285, 10.1016/S0735-1097(02)01952-6 · DOI · Paper page
  31. Graham, 2000, Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study, J Am Coll Cardiol, 36, 255, 10.1016/S0735-1097(00)00682-3 · DOI · Paper page
  32. Puley, 1999, Arrhythmia and survival in patients >18 years of age after the Mustard procedure for complete transposition of the great arteries, Am J Cardiol, 83, 1080, 10.1016/S0002-9149(99)00019-3 · DOI · Paper page
  33. Cohen, 1998, Sinus node function after a systematically staged Fontan procedure, Circulation, 98, II352
  34. Tzemos, 2009, Adverse left ventricular mechanics in adults with repaired tetralogy of Fallot, Am J Cardiol, 103, 420, 10.1016/j.amjcard.2008.09.101 · DOI
  35. Khairy, 2008, Implantable cardioverter-defibrillators in tetralogy of Fallot, Circulation, 117, 363, 10.1161/CIRCULATIONAHA.107.726372 · DOI · Paper page
  36. Vermeer, 2013, Ebstein anomaly associated with left ventricular noncompaction: an autosomal dominant condition that can be caused by mutations in MYH7, Am J Med Genet C Semin Med Genet, 163C, 178, 10.1002/ajmg.c.31365 · DOI
  37. Davlouros, 2002, Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction, J Am Coll Cardiol, 40, 2044, 10.1016/S0735-1097(02)02566-4 · DOI · Paper page
  38. Knauth, 2008, Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair, Heart, 94, 211, 10.1136/hrt.2006.104745 · DOI · Paper page
  39. Khairy, 2009, Catheter ablation in transposition of the great arteries with Mustard or Senning baffles, Heart Rhythm, 6, 283, 10.1016/j.hrthm.2008.11.022 · DOI
  40. Kammeraad, 2004, Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries, J Am Coll Cardiol, 44, 1095, 10.1016/j.jacc.2004.05.073 · DOI · Paper page
  41. Janousek, 1994, Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death, Z Kardiol, 83, 933
  42. Schwerzmann, 2009, Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries, Eur Heart J, 30, 1873, 10.1093/eurheartj/ehp179 · DOI · Paper page
  43. Hornung, 1998, Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries, Heart, 80, 322, 10.1136/hrt.80.4.322 · DOI
  44. Khairy, 2007, Univentricular heart, Circulation, 115, 800, 10.1161/CIRCULATIONAHA.105.592378 · DOI · Paper page
  45. Piran, 2002, Heart failure and ventricular dysfunction in patients with single or systemic right ventricles, Circulation, 105, 1189, 10.1161/hc1002.105182 · DOI · Paper page
  46. Gatzoulis, 2000, Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology, Heart, 83, 51, 10.1136/heart.83.1.51 · DOI
  47. 2001, Summary of recommendations—care of the adult with congenital heart disease, J Am Coll Cardiol, 37, 1167, 10.1016/S0735-1097(01)01281-5 · DOI
  48. Silversides, 2010, Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary, Can J Cardiol, 26, 143, 10.1016/S0828-282X(10)70352-4 · DOI · Paper page
  49. Baumgartner, 2010, ESC Guidelines for the management of grown-up congenital heart disease (new version 2010), Eur Heart J, 31, 2915, 10.1093/eurheartj/ehq249 · DOI · Paper page
  50. Garekar, 2005, Is it safe to perform cardiac catheterizations on adults with congenital heart disease in a pediatric catheterization laboratory?, Catheter Cardiovasc Interv, 66, 414, 10.1002/ccd.20537 · DOI
  51. Walsh, 2007, Interventional electrophysiology in patients with congenital heart disease, Circulation, 115, 3224, 10.1161/CIRCULATIONAHA.106.655753 · DOI · Paper page
  52. Landzberg, 2001, Task force 4: organization of delivery systems for adults with congenital heart disease, J Am Coll Cardiol, 37, 1187, 10.1016/S0735-1097(01)01275-X · DOI
  53. Verheugt, 2010, The emerging burden of hospital admissions of adults with congenital heart disease, Heart, 96, 872, 10.1136/hrt.2009.185595 · DOI · Paper page
  54. Cross, 2006, Transitional medicine: will emergency medicine physicians be ready for the growing population of adults with congenital heart disease?, Pediatr Emerg Care, 22, 775, 10.1097/01.pec.0000245178.13418.4f · DOI
  55. Green, 2011, 2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology, Can J Cardiol, 27, 859, 10.1016/j.cjca.2011.03.002 · DOI
  56. Vetter, 2005, ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 4: recommendations for training guidelines in pediatric cardiac electrophysiology endorsed by the Heart Rhythm Society, J Am Coll Cardiol, 46, 1391, 10.1016/j.jacc.2005.07.018 · DOI
  57. Walsh, 2013, Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society, Heart Rhythm, 10, 775, 10.1016/j.hrthm.2013.03.040 · DOI
  58. Naccarelli, 2008, Task force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management endorsed by the Heart Rhythm Society, J Am Coll Cardiol, 51, 374, 10.1016/j.jacc.2007.11.014 · DOI
  59. Khairy, 2008, Transcatheter ablation via a sternotomy approach as a hybrid procedure in a univentricular heart, Pacing Clin Electrophysiol, 31, 639, 10.1111/j.1540-8159.2008.01058.x · DOI
  60. Asgar, 2007, Recanalization of systemic venous baffles by radiofrequency perforation and stent implantation, Catheter Cardiovasc Interv, 70, 591, 10.1002/ccd.21171 · DOI
  61. Sherwin, 2013, Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts, Circ Arrhythm Electrophysiol, 6, 1032, 10.1161/CIRCEP.113.000313 · DOI
  62. Heggie, 2006, The anesthesiologist's role in adults with congenital heart disease, Cardiol Clin, 24, 571, 10.1016/j.ccl.2006.08.006 · DOI
  63. Patel, 2010, Care of the adult congenital heart disease patient in the United States: a summary of the current system, Pediatr Cardiol, 31, 511, 10.1007/s00246-009-9629-5 · DOI
  64. Attenhofer Jost, 2007, Ebstein's anomaly, Circulation, 115, 277, 10.1161/CIRCULATIONAHA.106.619338 · DOI · Paper page
  65. Connelly, 1996, Congenitally corrected transposition of the great arteries in the adult: functional status and complications, J Am Coll Cardiol, 27, 1238, 10.1016/0735-1097(95)00567-6 · DOI · Paper page
  66. Flinn, 1984, Cardiac rhythm after the Mustard operation for complete transposition of the great arteries, N Engl J Med, 310, 1635, 10.1056/NEJM198406213102504 · DOI · Paper page
  67. Broberg, 2011, Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of Fallot, Am J Cardiol, 107, 1215, 10.1016/j.amjcard.2010.12.026 · DOI · Paper page
  68. Mondesert, 2014, Diagnostic tools for arrhythmia detection in adults with congenital heart disease and heart failure, Heart Fail Clin, 10, 57, 10.1016/j.hfc.2013.09.009 · DOI
  69. Khairy, 2004, Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study, Circulation, 109, 1994, 10.1161/01.CIR.0000126495.11040.BD · DOI · Paper page
  70. Khairy, 2007, Clinical use of electrocardiography in adults with congenital heart disease, Circulation, 116, 2734, 10.1161/CIRCULATIONAHA.107.691568 · DOI
  71. Czosek, 2013, Utility of ambulatory monitoring in patients with congenital heart disease, Am J Cardiol, 111, 723, 10.1016/j.amjcard.2012.11.021 · DOI
  72. Rodriguez, 2012, Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory electrocardiography, Pediatr Cardiol, 33, 591, 10.1007/s00246-012-0183-1 · DOI
  73. Kenny, 2009, Single-centre use of implantable loop recorders in patients with congenital heart disease, Europace, 11, 303, 10.1093/europace/eun380 · DOI
  74. Inuzuka, 2012, Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term, Circulation, 125, 250, 10.1161/CIRCULATIONAHA.111.058719 · DOI · Paper page
  75. Zartner, 2012, Telemonitoring with implantable electronic devices in young patients with congenital heart diseases, Europace, 14, 1030, 10.1093/europace/eur434 · DOI
  76. Khairy, 2007, Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective, Nat Clin Pract Cardiovasc Med, 4, 292, 10.1038/ncpcardio0882 · DOI
  77. Junge, 2013, Comparison of late results of arterial switch versus atrial switch (Mustard procedure) operation for transposition of the great arteries, Am J Cardiol, 111, 1505, 10.1016/j.amjcard.2013.01.307 · DOI
  78. Khattab, 2013, Echocardiogram versus cardiac magnetic resonance imaging for assessing systolic function of subaortic right ventricle in adults with complete transposition of great arteries and previous atrial switch operation, Am J Cardiol, 111, 908, 10.1016/j.amjcard.2012.11.044 · DOI
  79. Marcotte, 2009, Evaluation of adult congenital heart disease by cardiac magnetic resonance imaging, Congenit Heart Dis, 4, 216, 10.1111/j.1747-0803.2009.00313.x · DOI
  80. Abadir, 2011, Electrophysiology and adult congenital heart disease: advances and options, Prog Cardiovasc Dis, 53, 281, 10.1016/j.pcad.2010.07.003 · DOI
  81. Giannakoulas, 2009, Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors, Am J Cardiol, 103, 1445, 10.1016/j.amjcard.2009.01.353 · DOI · Paper page
  82. Klewer, 2002, Comparison of accuracy of diagnosis of congenital heart disease by history and physical examination versus echocardiography, Am J Cardiol, 89, 1329, 10.1016/S0002-9149(02)02341-X · DOI
  83. Ridley, 2005, Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia, J Cardiovasc Electrophysiol, 16, 601, 10.1046/j.1540-8167.2005.40474.x · DOI
  84. Arenal, 2007, Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients, Heart Rhythm, 4, 316, 10.1016/j.hrthm.2006.10.032 · DOI
  85. Koyak, 2013, Postoperative arrhythmias in adults with congenital heart disease: incidence and risk factors, Int J Cardiol, 169, 139, 10.1016/j.ijcard.2013.08.087 · DOI
  86. Zipes, 2006, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
  87. Deroubaix, 2004, Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability, J Am Coll Cardiol, 44, 1918, 10.1016/j.jacc.2004.07.055 · DOI
  88. Khairy, 2013, Cardiovascular outcomes after the arterial switch operation for d-transposition of the great arteries, Circulation, 127, 331, 10.1161/CIRCULATIONAHA.112.135046 · DOI · Paper page
  89. Epstein, 2013, 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities, J Am Coll Cardiol, 61, e6, 10.1016/j.jacc.2012.11.007 · DOI · Paper page
  90. Alexander, 1999, Value of programmed ventricular stimulation in patients with congenital heart disease, J Cardiovasc Electrophysiol, 10, 1033, 10.1111/j.1540-8167.1999.tb00274.x · DOI
  91. Fishberger, 1997, Factors that influence the development of atrial flutter after the Fontan operation, J Thorac Cardiovasc Surg, 113, 80, 10.1016/S0022-5223(97)70402-1 · DOI · Paper page
  92. Gatzoulis, 1995, Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death, Circulation, 92, 231, 10.1161/01.CIR.92.2.231 · DOI · Paper page
  93. Cullen, 1994, Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study, J Am Coll Cardiol, 23, 1151, 10.1016/0735-1097(94)90604-1 · DOI
  94. McLeod, 1999, Reduced heart rate variability following repair of tetralogy of Fallot, Heart, 81, 656, 10.1136/hrt.81.6.656 · DOI
  95. Davos, 2009, Heart rate turbulence in adults with repaired tetralogy of Fallot, Int J Cardiol, 135, 308, 10.1016/j.ijcard.2008.03.096 · DOI
  96. Lammers, 2006, Impaired cardiac autonomic nervous activity predicts sudden cardiac death in patients with operated and unoperated congenital cardiac disease, J Thorac Cardiovasc Surg, 132, 647, 10.1016/j.jtcvs.2006.03.057 · DOI
  97. Rosenberg, 2013, Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study, Pacing Clin Electrophysiol, 36, 328, 10.1111/pace.12053 · DOI · Paper page
  98. Keane, 1993, Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis, Circulation, 87, I16
  99. Gatzoulis, 2000, Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction?, Heart, 84, 409, 10.1136/heart.84.4.409 · DOI
  100. Ghai, 2002, Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot, J Am Coll Cardiol, 40, 1675, 10.1016/S0735-1097(02)02344-6 · DOI · Paper page
  101. Daliento, 1999, Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot, Heart, 81, 650, 10.1136/hrt.81.6.650 · DOI
  102. Anderson, 2013, Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, 1935, 10.1016/j.jacc.2013.02.001 · DOI · Paper page
  103. Balling, 2000, Intracardiac thrombus formation after the Fontan operation, J Thorac Cardiovasc Surg, 119, 745, 10.1016/S0022-5223(00)70010-9 · DOI · Paper page
  104. Khairy, 2013, Thrombosis in congenital heart disease, Expert Rev Cardiovasc Ther, 11, 1579, 10.1586/14779072.2013.854703 · DOI
  105. Hoffmann, 2010, Cerebrovascular accidents in adult patients with congenital heart disease, Heart, 96, 1223, 10.1136/hrt.2010.196147 · DOI
  106. Hoyer, 2007, The safety and efficacy of ibutilide in children and in patients with congenital heart disease, Pacing Clin Electrophysiol, 30, 1003, 10.1111/j.1540-8159.2007.00799.x · DOI
  107. Rao, 2009, Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol, Int J Cardiol, 136, 253, 10.1016/j.ijcard.2008.04.060 · DOI
  108. Kowey, 1996, Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter, Am J Cardiol, 78, 46, 10.1016/S0002-9149(96)00566-8 · DOI
  109. Gowda, 2004, Female preponderance in ibutilide-induced torsade de pointes, Int J Cardiol, 95, 219, 10.1016/j.ijcard.2003.04.034 · DOI
  110. Gowda, 2003, Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety, Am J Ther, 10, 259, 10.1097/00045391-200307000-00005 · DOI
  111. Suman-Horduna, 2013, Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure, J Am Coll Cardiol, 61, 455, 10.1016/j.jacc.2012.10.031 · DOI
  112. Talajic, 2010, Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation, J Am Coll Cardiol, 55, 1796, 10.1016/j.jacc.2010.01.023 · DOI
  113. Jenkins, 2005, Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study, Am Heart J, 149, 112, 10.1016/j.ahj.2004.03.065 · DOI · Paper page
  114. Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, 1834, 10.1056/NEJMoa021375 · DOI · Paper page
  115. Hohnloser, 2000, Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial, Lancet, 356, 1789, 10.1016/S0140-6736(00)03230-X · DOI · Paper page
  116. Van Gelder, 2006, RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II, Am Heart J, 152, 420, 10.1016/j.ahj.2006.02.033 · DOI
  117. Mulder, 2013, Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study, Eur J Heart Fail, 15, 1311, 10.1093/eurjhf/hft093 · DOI
  118. Skanes, 2012, Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control, Can J Cardiol, 28, 125, 10.1016/j.cjca.2012.01.021 · DOI · Paper page
  119. Whitbeck, 2013, Increased mortality among patients taking digoxin—analysis from the AFFIRM study, Eur Heart J, 34, 1481, 10.1093/eurheartj/ehs348 · DOI · Paper page
  120. 1989, The Cardiac Arrhythmia Suppression Trial (CAST) Investigators, N Engl J Med, 321, 406
  121. 1992, The Cardiac Arrhythmia Suppression Trial II Investigators, N Engl J Med, 327, 227
  122. Flaker, 1992, Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators, J Am Coll Cardiol, 20, 527, 10.1016/0735-1097(92)90003-6 · DOI · Paper page
  123. Stevenson, 1996, Improving survival for patients with atrial fibrillation and advanced heart failure, J Am Coll Cardiol, 28, 1458, 10.1016/S0735-1097(96)00358-0 · DOI · Paper page
  124. Duff, 1995, Proarrhythmia of a class Ic drug: suppression by combination with a drug prolonging repolarization in the dog late after infarction, J Pharmacol Exp Ther, 274, 508, 10.1016/S0022-3565(25)10665-4 · DOI
  125. Lafuente-Lafuente, 2012, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev, 5
  126. Koyak, 2013, Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias, Am J Cardiol, 112, 1461, 10.1016/j.amjcard.2013.07.029 · DOI · Paper page
  127. Miyazaki, 2008, Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease, Circ J, 72, 1998, 10.1253/circj.CJ-08-0194 · DOI
  128. Beaufort-Krol, 1997, Sotalol for atrial tachycardias after surgery for congenital heart disease, Pacing Clin Electrophysiol, 20, 2125, 10.1111/j.1540-8159.1997.tb03642.x · DOI
  129. Pfammatter, 1995, Efficacy and proarrhythmia of oral sotalol in pediatric patients, J Am Coll Cardiol, 26, 1002, 10.1016/0735-1097(95)00268-3 · DOI
  130. Roy, 2000, Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators, N Engl J Med, 342, 913, 10.1056/NEJM200003303421302 · DOI · Paper page
  131. Thorne, 1999, Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease, Circulation, 100, 149, 10.1161/01.CIR.100.2.149 · DOI
  132. Stan, 2013, Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease—a cohort study, Int J Cardiol, 167, 821, 10.1016/j.ijcard.2012.02.015 · DOI
  133. Stan, 2012, A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease, J Thyroid Res, 2012, 210529
  134. Fuster, 2011, 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation, J Am Coll Cardiol, 57, e101, 10.1016/j.jacc.2010.09.013 · DOI · Paper page
  135. Page, 2011, Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial), Am J Cardiol, 107, 1019, 10.1016/j.amjcard.2010.11.028 · DOI
  136. Duray, 2011, Effects of dronedarone on clinical outcomes in patients with lone atrial fibrillation: pooled post hoc analysis from the ATHENA/EURIDIS/ADONIS studies, J Cardiovasc Electrophysiol, 22, 770, 10.1111/j.1540-8167.2010.02006.x · DOI
  137. Kober, 2008, Increased mortality after dronedarone therapy for severe heart failure, N Engl J Med, 358, 2678, 10.1056/NEJMoa0800456 · DOI · Paper page
  138. Connolly, 2011, Dronedarone in high-risk permanent atrial fibrillation, N Engl J Med, 365, 2268, 10.1056/NEJMoa1109867 · DOI · Paper page
  139. Gwilt, 1991, UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells, J Pharmacol Exp Ther, 256, 318, 10.1016/S0022-3565(25)23172-X · DOI · Paper page
  140. Ferguson, 1999, Meeting highlights. Highlights of the 71st scientific sessions of the American Heart Association, Circulation, 99, 2486, 10.1161/01.CIR.99.19.2486 · DOI
  141. Kober, 2000, Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial, Lancet, 356, 2052, 10.1016/S0140-6736(00)03402-4 · DOI · Paper page
  142. Pedersen, 2001, Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy, Circulation, 104, 292, 10.1161/01.CIR.104.3.292 · DOI · Paper page
  143. Torp-Pedersen, 1999, Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group, N Engl J Med, 341, 857, 10.1056/NEJM199909163411201 · DOI · Paper page
  144. Wells, 2009, Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study, Pacing Clin Electrophysiol, 32, 1313, 10.1111/j.1540-8159.2009.02479.x · DOI
  145. Akca, 2012, Acute and long-term outcomes of catheter ablation using remote magnetic navigation in patients with congenital heart disease, Am J Cardiol, 110, 409, 10.1016/j.amjcard.2012.03.040 · DOI
  146. Triedman, 2005, Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease, Heart Rhythm, 2, 700, 10.1016/j.hrthm.2005.03.017 · DOI
  147. Kannankeril, 2003, Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease, Am J Cardiol, 92, 879, 10.1016/S0002-9149(03)00908-1 · DOI
  148. Walsh, 2002, Arrhythmias in patients with congenital heart disease, Card Electrophysiol Rev, 6, 422, 10.1023/A:1021192526642 · DOI
  149. Triedman, 2001, Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia, Circulation, 103, 2060, 10.1161/01.CIR.103.16.2060 · DOI
  150. Hebe, 2000, Radiofrequency catheter ablation of tachycardia in patients with congenital heart disease, Pediatr Cardiol, 21, 557, 10.1007/s002460010134 · DOI
  151. Banchs, 2014, Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease, Congenit Heart Dis, 9, 221, 10.1111/chd.12129 · DOI
  152. Szymanski, 2010, Endogenous catecholamine levels and function of the systemic right ventricle following atrial switch, Int J Cardiol, 138, 81, 10.1016/j.ijcard.2008.10.040 · DOI
  153. Ammash, 2012, Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease, Int J Cardiol, 154, 270, 10.1016/j.ijcard.2010.09.028 · DOI · Paper page
  154. Klein, 1997, Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography, Ann Intern Med, 126, 200, 10.7326/0003-4819-126-3-199702010-00004 · DOI · Paper page
  155. Manning, 1995, Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study, J Am Coll Cardiol, 25, 1354, 10.1016/0735-1097(94)00560-D · DOI · Paper page
  156. Roldan, 2013, The HAS-BLED score has better prediction accuracy for major bleeding than the CHADS or CHADS-VASc scores In anticoagulated patients with atrial fibrillation, J Am Coll Cardiol, 62, 2199, 10.1016/j.jacc.2013.08.1623 · DOI · Paper page
  157. Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 · DOI · Paper page
  158. Olesen, 2012, The value of the CHA2DS2–VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study, Thromb Haemost, 107, 1172, 10.1160/TH12-03-0175 · DOI · Paper page
  159. Idorn, 2013, Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology, Pediatr Cardiol, 34, 262, 10.1007/s00246-012-0431-4 · DOI
  160. Desimone, 2013, Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale, Circulation, 128, 1433, 10.1161/CIRCULATIONAHA.113.003540 · DOI
  161. Khairy, 2006, Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study, Circulation, 113, 2391, 10.1161/CIRCULATIONAHA.106.622076 · DOI · Paper page
  162. Jahangiri, 1997, Coagulation factor abnormalities after the Fontan procedure and its modifications, J Thorac Cardiovasc Surg, 113, 989, 10.1016/S0022-5223(97)70283-6 · DOI
  163. van Nieuwenhuizen, 1999, Abnormalities in liver function and coagulation profile following the Fontan procedure, Heart, 82, 40, 10.1136/hrt.82.1.40 · DOI
  164. Tomita, 2001, Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations, Cardiol Young, 11, 62, 10.1017/S1047951100012439 · DOI
  165. Khairy, 2012, The extracardiac conduit is not the preferred Fontan approach for patients with univentricular hearts, Circulation, 126, 2516, 10.1161/CIRCULATIONAHA.111.075036 · DOI
  166. Valente, 2010, The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study, J Am Coll Cardiol, 56, 144, 10.1016/j.jacc.2010.02.048 · DOI
  167. Ravn, 2001, Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection, Heart, 85, 61, 10.1136/heart.85.1.61 · DOI
  168. Monagle, 2011, A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children, J Am Coll Cardiol, 58, 645, 10.1016/j.jacc.2011.01.061 · DOI · Paper page
  169. Potter, 2013, Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation, Int J Cardiol, 168, 3940, 10.1016/j.ijcard.2013.06.058 · DOI
  170. Fyfe, 1991, Transesophageal echocardiography detects thrombus formation not identified by transthoracic echocardiography after the Fontan operation, J Am Coll Cardiol, 18, 1733, 10.1016/0735-1097(91)90512-8 · DOI
  171. 1994, Analysis of pooled data from five randomized controlled trials, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007 · DOI · Paper page
  172. Morley, 1996, Atrial fibrillation, anticoagulation, and stroke, Am J Cardiol, 77, 38A, 10.1016/S0002-9149(97)89116-3 · DOI
  173. Howard, 1997, Primary stroke prevention in nonvalvular atrial fibrillation: implementing the clinical trial findings, Ann Pharmacother, 31, 1187, 10.1177/106002809703101012 · DOI
  174. van Walraven, 2002, Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis, JAMA, 288, 2441, 10.1001/jama.288.19.2441 · DOI · Paper page
  175. McCrindle, 2013, Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure, J Am Coll Cardiol, 61, 346, 10.1016/j.jacc.2012.08.1023 · DOI · Paper page
  176. Nolan, 2005, European Resuscitation Council guidelines for resuscitation, Section 4. Adult advanced life support. Resuscitation 2005;67, S39
  177. Gorgels, 1996, Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia, Am J Cardiol, 78, 43, 10.1016/S0002-9149(96)00224-X · DOI · Paper page
  178. Sharma, 1990, Hemodynamic effects of intravenous procainamide during ventricular tachycardia, Am Heart J, 119, 1034, 10.1016/S0002-8703(05)80232-7 · DOI
  179. Callans, 1992, Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms, J Am Coll Cardiol, 19, 111, 10.1016/0735-1097(92)90060-Z · DOI
  180. Pacifico, 1999, Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group, N Engl J Med, 340, 1855, 10.1056/NEJM199906173402402 · DOI · Paper page
  181. Piccini, 2009, Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials, Eur Heart J, 30, 1245, 10.1093/eurheartj/ehp100 · DOI · Paper page
  182. Moak, 1987, Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease, J Am Coll Cardiol, 10, 824, 10.1016/S0735-1097(87)80276-0 · DOI
  183. Kavey, 1982, Phenytoin therapy for ventricular arrhythmias occurring late after surgery for congenital heart disease, Am Heart J, 104, 794, 10.1016/0002-8703(82)90013-8 · DOI
  184. Garson, 1980, Control of late postoperative ventricular arrhythmias with phenytoin in young patients, Am J Cardiol, 46, 290, 10.1016/0002-9149(80)90073-9 · DOI
  185. Deal, 1987, Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot, Am J Cardiol, 59, 1380, 10.1016/0002-9149(87)90924-6 · DOI
  186. Furushima, 2006, Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome, J Electrocardiol, 39, 219, 10.1016/j.jelectrocard.2005.08.005 · DOI
  187. Gao, 2013, Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator, J Cardiovasc Pharmacol, 62, 199, 10.1097/FJC.0b013e31829651fe · DOI
  188. Windram, 2013, New directives in cardiac imaging: imaging the adult with congenital heart disease, Can J Cardiol, 29, 830, 10.1016/j.cjca.2013.04.020 · DOI
  189. Kilner, 2011, Imaging congenital heart disease in adults, Br J Radiol, 84, S258, 10.1259/bjr/74240815 · DOI
  190. Singh, 2011, Percutaneous transhepatic venous access for catheter ablation procedures in patients with interruption of the inferior vena cava, Circ Arrhythm Electrophysiol, 4, 235, 10.1161/CIRCEP.110.960856 · DOI
  191. Brown, 2009, The adult with congenital heart disease: medical and surgical considerations for management, Curr Opin Pediatr, 21, 561, 10.1097/MOP.0b013e3283302685 · DOI
  192. Tops, 2006, Fusion of electroanatomical activation maps and multislice computed tomography to guide ablation of a focal atrial tachycardia in a Fontan patient, J Cardiovasc Electrophysiol, 17, 431, 10.1111/j.1540-8167.2005.00305.x · DOI
  193. Wong, 2004, Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias, Circulation, 109, 2319, 10.1161/01.CIR.0000129766.18065.DC · DOI
  194. Gulotta, 1959, Ebstein's anomaly associated with the Wolff-Parkinson-White syndrome, Heart Cent Bull (Roslyn), 16, 16
  195. Levine, 1993, Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome, Am J Cardiol, 72, 689, 10.1016/0002-9149(93)90886-H · DOI
  196. Bae, 2005, Twin AV node and induced supraventricular tachycardia in Fontan palliation patients, Pacing Clin Electrophysiol, 28, 126, 10.1111/j.1540-8159.2005.09450.x · DOI
  197. Hager, 2005, Congenital and surgically acquired Wolff-Parkinson-White syndrome in patients with tricuspid atresia, J Thorac Cardiovasc Surg, 130, 48, 10.1016/j.jtcvs.2004.11.017 · DOI
  198. McCanta, 2011, Cryoablation of the slow atrioventricular nodal pathway via a transbaffle approach in a patient with the Mustard procedure for d-transposition of the great arteries, Congenit Heart Dis, 6, 479, 10.1111/j.1747-0803.2011.00515.x · DOI
  199. Rausch, 2010, Cryothermal catheter ablation of atrioventricular nodal reentrant tachycardia in a pediatric patient after atrioventricular canal repair, Congenit Heart Dis, 5, 66, 10.1111/j.1747-0803.2009.00333.x · DOI
  200. Billakanty, 2009, Radiofrequency catheter ablation of AV nodal reentrant tachycardia in situs inversus totalis, Pacing Clin Electrophysiol, 32, 403, 10.1111/j.1540-8159.2008.02252.x · DOI

200 of 584 shown

Cited by

See all 230

Metadata

Authors
Khairy, P., Van Hare, G. F., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., Groot, N. D., Dubin, A. M., Harris, L., Janousek, J., Kanter, R. J., Karpawich, P. P., Perry, J. C., Seslar, S. P., Shah, M. J., Silka, M. J., Triedman, J. K., Walsh, E. P., & Warnes, C. A.
Venue
Canadian Journal of Cardiology
Publisher
Elsevier BV
Published
2014-10
Volume
30
Issue
10
Pages
e1-e63
ISSN
0828-282X (ISSN-L)
OpenAlex
W1995076163
Cited by
230
References
53
FWCI
11.91
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.